A detailed history of Great Point Partners LLC transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Great Point Partners LLC holds 2,790,698 shares of PMN stock, worth $2.51 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares
2,790,698
Holding current value
$2.51 Million
% of portfolio
1.61%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.2 - $2.27 $3.35 Million - $6.33 Million
2,790,698 New
2,790,698 $3.49 Million

Others Institutions Holding PMN

About ProMIS Neurosciences Inc.


  • Ticker PMN
  • Exchange OTC
  • Description
  • ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...
More about PMN
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.